about us

Meet the Team

Vineet Gupta, PhD

Vineet Gupta, PhD

Founder, CEO

Vineet Gupta is the Founder and CEO of AlloSite. He is known for his expertise in integrins and groundbreaking work on allosteric agonists as a therapeutic approach. With a successful entrepreneurial background, he has taken two startups to exit, including Adhaere Pharmaceuticals, which was acquired by Gossamer Bio, Inc. Vineet’s extensive research in integrins, drug discovery, and therapeutic development has led to numerous publications and over 50 patents. He holds advanced degrees from prestigious institutions like the Indian Institute of Technology, Delhi (IIT Delhi), and the University of Rochester, and has held faculty positions at Harvard Medical School and the University of Miami. Currently, Vineet is an Endowed Professor and Vice Chair for Innovation in the Department of Internal Medicine at Rush University Medical Center, where he also holds The Charles Arthur Weaver Chair for Cancer Research.
Antonio Barbosa

Antonio Barbosa

Vice President, Research

Dr. Tony Barbosa, VP of Research at AlloSite, oversees groundbreaking medicines for kidney diseases. With 25+ years in drug discovery, he’s recognized for three NIH SBIR grants and an Ed and Ethel Moore Alzheimer’s Disease Research Program grant. His expertise includes oncology and immunology & inflammation, targeting diseases like Alzheimer’s, cancer, and kidney disease. Previously, he directed chemistry at Adhaere Pharmaceuticals, whose efforts led to immuno-oncology clinical trials in its acquisition by Gossamer Bio, Inc. Dr. Barbosa is also an Associate Professor at Ave Maria University, focusing on new Alzheimer’s treatments. He holds a Ph.D. in Organic Chemistry from the University of Rochester and boasts patents in oncology and immunology & inflammation.
Darlah López-Rodriguez

Darlah López-Rodriguez

Staff Scientist

Darlah Lopez-Rodriguez is a Staff Scientist at AlloSite, where she develops novel assays to advance our programs. Darlah received her PhD from the University of Miami and her postdoctoral training at the same institution. She has over 10 years of experience in experimental biology and assay development in cell biology and immunology.

Santiago Balza Pineda

Santiago Balza Pineda

Research Scientist

Santiago Balza Pineda is a Research and Data Scientist at AlloSite, where he develops novel assays for therapeutic discovery, and implements the machine learning elements of the antibody development and optimization platform. Santiago received his Bachelor’s and Master’s of Science and Engineering in Biomedical Engineering from Johns Hopkins University. His expertise lies in immunology and protein engineering, with 5+ years of experience in the field and wet lab R&D.

Advisors

Ashish Khanna

Ashish Khanna

Co-founder CFO, CBO, Aptinyx

Julio Medina, Ph.D.

Julio Medina, Ph.D.

Founder, CEO R2M Pharma

Mitchell Mutz, PhD

Mitchell Mutz, PhD

Entrepreneur Partner, Vivo Capital

Regulatory

Consultants

FDA Regulations, Clinical Pharmacology, CMC, Toxicology, and DMPK

© 2023 AlloSite Therapeutics.       All rights reserved.